Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
The high morbidity and mortality rates in hemodialysis (HD) patients are due, at least in part, to their increased risk for cardiovascular diseases (CVD). This prospective study evaluated the effect of growth hormone (GH) on a number of CVD risk markers in adult patients on HD.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Nephron Clinical Practice |
Vol/bind | 115 |
Udgave nummer | 3 |
Sider (fra-til) | c213-26 |
Antal sider | 14 |
ISSN | 1660-2110 |
DOI | |
Status | Udgivet - 1 jan. 2010 |
ID: 34154046